Advertisement

Vasospasm: My First 25 Years—What Worked? What Didn’t? What Next?

  • R. Loch MacdonaldEmail author
Part of the Acta Neurochirurgica Supplement book series (NEUROCHIRURGICA, volume 120)

Abstract

Angiographic vasospasm as a complication of aneurysmal and other types of subarachnoid hemorrhage (SAH) was identified about 62 years ago. It is now hypothesized that angiographic vasospasm contributes to delayed cerebral ischemia (DCI) by multiple pathways, including reduced blood flow from angiographic vasospasm as well as microcirculatory constriction, microthrombosis, cortical spreading ischemia, and delayed effects of early brain injury. It is likely that other factors, such as systemic complications, effects of the subarachnoid blood, brain collateral and anastomotic blood flow, and the genetic and epigenetic makeup of the patient, contribute to the individual’s response to SAH. Treatment of aneurysmal SAH and DCI includes neurocritical care management, early aneurysm repair, prophylactic administration of nimodipine, and rescue therapies (induced hypertension and balloon or pharmacologic angioplasty) if the patient develops DCI. Well-designed clinical trials of tirilazad, clasozentan, antiplatelet drugs, and magnesium have been conducted using more than a 1,000 patients each. Some of these drugs have almost purely vascular effects; other drugs are theoretically neuroprotective as well, but they share in common the ability to reduce angiographic vasospasm and, in many cases, DCI, but have no effect on clinical outcome. Experimental research in SAH continues to identify new targets for therapy. Challenges for the future will be to identify the most promising drugs to advance from preclinical studies and to understand why clinical trials have so frequently failed to show drug benefit on clinical outcome. Similar issues with treatment of ischemic stroke are being addressed by suggestions for improving the quality of experimental studies, collaborative preclinical trials, and multinational, multicenter clinical studies that can rapidly include many patients and be large enough to account for numerous factors that conspire to disrupt clinical trials.

Keywords

Subarachnoid hemorrhage Vasospasm Brain injury 

Notes

Acknowledgements

RLM receives grant support from the Physicians Services Incorporated Foundation, Brain Aneurysm Foundation, Canadian Stroke Network, Canadian Institutes of Health Research, and Heart and Stroke Foundation of Ontario.

Conflict of Interest Statement 

RLM is Chief Scientific Officer of Edge Therapeutics.

References

  1. 1.
    Al-Khindi T, Macdonald RL, Schweizer TA (2010) Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke 41:e519–e536PubMedCrossRefGoogle Scholar
  2. 2.
    Barr HL, Britton J, Smyth AR, Fogarty AW (2011) Association between socioeconomic status, sex, and age at death from cystic fibrosis in England and Wales (1959 to 2008): cross sectional study. BMJ 343:d4662PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Broderick JP, Brott TG, Duldner JE, Tomsick T, Leach A (1994) Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke 25:1342–1347PubMedCrossRefGoogle Scholar
  4. 4.
    Chou CH, Reed SD, Allsbrook JS, Steele JL, Schulman KA, Alexander MJ (2010) Costs of vasospasm in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 67:345–352PubMedCrossRefGoogle Scholar
  5. 5.
    Connolly ES Jr, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, Hoh BL, Kirkness CJ, Naidech AM, Ogilvy CS, Patel AB, Thompson BG, Vespa P (2012) Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 43:1711–1737PubMedCrossRefGoogle Scholar
  6. 6.
    Crowley RW, Medel R, Dumont AS, Ilodigwe D, Kassell NF, Mayer SA, Ruefenacht D, Schmiedek P, Weidauer S, Pasqualin A, Macdonald RL (2011) Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage. Stroke 42:919–923PubMedCrossRefGoogle Scholar
  7. 7.
    Dankbaar JW, Rijsdijk M, van der Schaaf IC, Velthuis BK, Wermer MJ, Rinkel GJ (2009) Relationship between vasospasm, cerebral perfusion, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Neuroradiology 51:813–819PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    Dankbaar JW, Slooter AJ, Rinkel GJ, van der Schaaf IC (2010) Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review. Crit Care 14:R23PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    de Rooij NK, Rinkel GJ, Dankbaar JW, Frijns CJ (2013) Delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review of clinical, laboratory, and radiological predictors. Stroke 44:43–54PubMedCrossRefGoogle Scholar
  10. 10.
    Diringer MN, Bleck TP, Claude HJ III, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, Hanggi D, Hoh BL, Lanzino G, Le RP, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G (2011) Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care 15:211–240PubMedCrossRefGoogle Scholar
  11. 11.
    Dirnagl U, Hakim A, Macleod M, Fisher M, Howells D, Alan SM, Steinberg G, Planas A, Boltze J, Savitz S, Iadecola C, Meairs S (2013) A concerted appeal for international cooperation in preclinical stroke research. Stroke 44:1754–1760PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Doczi T, Joo F, Adam G, Bozoky B, Szerdahelyi P (1986) Blood-brain barrier damage during the acute stage of subarachnoid hemorrhage, as exemplified by a new animal model. Neurosurgery 18:733–739PubMedCrossRefGoogle Scholar
  13. 13.
    Dorhout Mees SM, Kerr RS, Rinkel GJ, Algra A, Molyneux AJ (2012) Occurrence and impact of delayed cerebral ischemia after coiling and after clipping in the International Subarachnoid Aneurysm Trial (ISAT). J Neurol 259:679–683PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Dorhout Mees SM, Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J (2007) Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 3:CD000277Google Scholar
  15. 15.
    Dorhout Mees SM, van den Bergh WM, Algra A, Rinkel GJ (2007) Antiplatelet therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 4:CD006184Google Scholar
  16. 16.
    Dreier JP (2011) The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med 17:439–447PubMedCrossRefGoogle Scholar
  17. 17.
    Dreier JP, Windmuller O, Petzold G, Lindauer U, Einhaupl KM, Dirnagl U (2002) Ischemia triggered by red blood cell products in the subarachnoid space is inhibited by nimodipine administration or moderate volume expansion/hemodilution in rats. Neurosurgery 51:1457–1465PubMedGoogle Scholar
  18. 18.
    Echlin FA (1980) Some historical remarks. In: Wilkins RH (ed) Cerebral arterial spasm. Williams and Wilkins, Baltimore, pp 1–6Google Scholar
  19. 19.
    Espinosa F, Weir B, Overton T, Castor W, Grace M, Boisvert D (1984) A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys. Part 1: clinical and radiological findings. J Neurosurg 60:1167–1175PubMedCrossRefGoogle Scholar
  20. 20.
    Feigin V, Anderson N, Rinkel G, Algra A, van Gijn J, Bennett DA (2005) Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage. Cochrane Database Syst Rev 3:CD004583Google Scholar
  21. 21.
    Findlay JM, Deagle GM (1998) Causes of morbidity and mortality following intracranial aneurysm rupture. Can J Neurol Sci 25:209–215PubMedGoogle Scholar
  22. 22.
    Friedrich B, Muller F, Feiler S, Scholler K, Plesnila N (2012) Experimental subarachnoid hemorrhage causes early and long-lasting microarterial constriction and microthrombosis: an in-vivo microscopy study. J Cereb Blood Flow Metab 32:447–455PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Fujii M, Yan J, Rolland WB, Soejima Y, Caner B, Zhang JH (2013) Early brain injury, an evolving frontier in subarachnoid hemorrhage research. Transl Stroke Res 4:432–446PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Golan E, Vasquez DN, Ferguson ND, Adhikari NK, Scales DC (2013) Prophylactic magnesium for improving neurologic outcome after aneurysmal subarachnoid hemorrhage: systematic review and meta-analysis. J Crit Care 28:173–181PubMedCrossRefGoogle Scholar
  25. 25.
    Guo J, Shi Z, Yang K, Tian JH, Jiang L (2012) Endothelin receptor antagonists for subarachnoid hemorrhage. Cochrane Database Syst Rev 9:CD008354PubMedGoogle Scholar
  26. 26.
    Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schunemann HJ (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924–926PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Hill MD, Martin RH, Mikulis D, Wong JH, Silver FL, terBrugge KG, Milot G, Clark WM, Macdonald RL, Kelly ME, Boulton M, Fleetwood I, McDougall C, Gunnarsson T, Chow M, Lum C, Dodd R, Poublanc J, Krings T, Demchuk AM, Goyal M, Anderson R, Bishop J, Garman D, Tymianski M (2012) Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol 11:942–950PubMedCrossRefGoogle Scholar
  28. 28.
    Jang YG, Ilodigwe D, Macdonald RL (2009) Metaanalysis of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care 10:141–147PubMedCrossRefGoogle Scholar
  29. 29.
    Jones DT, Jager N, Kool M, Zichner T, Hutter B, Sultan M, Cho YJ, Pugh TJ, Hovestadt V, Stutz AM, Rausch T, Warnatz HJ, Ryzhova M, Bender S, Sturm D, Pleier S, Cin H, Pfaff E, Sieber L, Wittmann A, Remke M, Witt H, Hutter S, Tzaridis T, Weischenfeldt J, Raeder B, Avci M, Amstislavskiy V, Zapatka M, Weber UD, Wang Q, Lasitschka B, Bartholomae CC, Schmidt M, von Kalle C, Ast V, Lawerenz C, Eils J, Kabbe R, Benes V, van Sluis P, Koster J, Volckmann R, Shih D, Betts MJ, Russell RB, Coco S, Tonini GP, Schuller U, Hans V, Graf N, Kim YJ, Monoranu C, Roggendorf W, Unterberg A, Herold-Mende C, Milde T, Kulozik AE, von Deimling A, Witt O, Maass E, Rossler J, Ebinger M, Schuhmann MU, Fruhwald MC, Hasselblatt M, Jabado N, Rutkowski S, von Bueren AO, Williamson D, Clifford SC, McCabe MG, Collins VP, Wolf S, Wiemann S, Lehrach H, Brors B, Scheurlen W, Felsberg J, Reifenberger G, Northcott PA, Taylor MD, Meyerson M, Pomeroy SL, Yaspo ML, Korbel JO, Korshunov A, Eils R, Pfister SM, Lichter P (2012) Dissecting the genomic complexity underlying medulloblastoma. Nature 488:100–105PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Khurana VG, Sohni YR, Mangrum WI, McClelland RL, O’Kane DJ, Meyer FB, Meissner I (2004) Endothelial nitric oxide synthase gene polymorphisms predict susceptibility to aneurysmal subarachnoid hemorrhage and cerebral vasospasm. J Cereb Blood Flow Metab 24:291–297PubMedCrossRefGoogle Scholar
  31. 31.
    Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010) Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 8:e1000412PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Komotar RJ, Schmidt JM, Starke RM, Claassen J, Wartenberg KE, Lee K, Badjatia N, Connolly ES Jr, Mayer SA (2009) Resuscitation and critical care of poor-grade subarachnoid hemorrhage. Neurosurgery 64:397–410PubMedCrossRefGoogle Scholar
  33. 33.
    Kramer AH, Fletcher JJ (2011) Locally-administered intrathecal thrombolytics following aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurocrit Care 14:489–499PubMedCrossRefGoogle Scholar
  34. 34.
    Lapchak PA, Zhang JH, Noble-Haeusslein LJ (2013) RIGOR guidelines: escalating STAIR and STEPS for effective translational research. Transl Stroke Res 4:279–285PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Liu GJ, Wang ZJ, Wang YF, Xu LL, Wang XL, Liu Y, Luo GJ, He GH, Zeng YJ (2012) Systematic assessment and meta-analysis of the efficacy and safety of fasudil in the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage. Eur J Clin Pharmacol 68:131–139Google Scholar
  36. 36.
    Lovelock CE, Rinkel GJ, Rothwell PM (2010) Time trends in outcome of subarachnoid hemorrhage: population-based study and systematic review. Neurology 74:1494–1501PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Macdonald RL (2013) History and definition of delayed cerebral ischemia. Acta Neurochir Suppl 115:3–7PubMedGoogle Scholar
  38. 38.
    Macdonald RL (2014) Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol 10:44–58Google Scholar
  39. 39.
    Macdonald RL, Cusimano MD, Etminan N, Hanggi D, Hasan D, Ilodigwe D, Jaja B, Lantigua H, Le RP, Lo B, Louffat-Olivares A, Mayer S, Molyneux A, Quinn A, Schweizer TA, Schenk T, Spears J, Todd M, Torner J, Vergouwen MD, Wong GK (2013) Subarachnoid Hemorrhage International Trialists Data Repository (SAHIT). World Neurosurg 79:418–422PubMedCrossRefGoogle Scholar
  40. 40.
    Macdonald RL, Rosengart A, Huo D, Karrison T (2003) Factors associated with the development of vasospasm after planned surgical treatment of aneurysmal subarachnoid hemorrhage. J Neurosurg 99:644–652PubMedCrossRefGoogle Scholar
  41. 41.
    Mahaney KB, Todd MM, Bayman EO, Torner JC (2012) Acute postoperative neurological deterioration associated with surgery for ruptured intracranial aneurysm: incidence, predictors, and outcomes. J Neurosurg 116:1267–1278PubMedCrossRefGoogle Scholar
  42. 42.
    Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, Holman R (2002) International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 360:1267–1274PubMedCrossRefGoogle Scholar
  43. 43.
    Nau R, Haase S, Bunkowski S, Bruck W (2002) Neuronal apoptosis in the dentate gyrus in humans with subarachnoid hemorrhage and cerebral hypoxia. Brain Pathol 12:329–336PubMedGoogle Scholar
  44. 44.
    Rosengart AJ, Schultheiss KE, Tolentino J, Macdonald RL (2007) Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke 38:2315–2321PubMedCrossRefGoogle Scholar
  45. 45.
    Scott RB, Eccles F, Molyneux AJ, Kerr RS, Rothwell PM, Carpenter K (2010) Improved cognitive outcomes with endovascular coiling of ruptured intracranial aneurysms: neuropsychological outcomes from the International Subarachnoid Aneurysm Trial (ISAT). Stroke 41:1743–1747PubMedCrossRefGoogle Scholar
  46. 46.
    Sehba FA, Hou J, Pluta RM, Zhang JH (2012) The importance of early brain injury after subarachnoid hemorrhage. Prog Neurobiol 97:14–37PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Smith-Bindman R, Lipson J, Marcus R, Kim KP, Mahesh M, Gould R, de Berrington GA, Miglioretti DL (2009) Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 169:2078–2086PubMedCrossRefGoogle Scholar
  48. 48.
    Stein SC, Browne KD, Chen XH, Smith DH, Graham DI (2006) Thromboembolism and delayed cerebral ischemia after subarachnoid hemorrhage: an autopsy study. Neurosurgery 59:781–787PubMedCrossRefGoogle Scholar
  49. 49.
    Steiner T, Juvela S, Unterberg A, Jung C, Forsting M, Rinkel G (2013) European stroke organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis 35:93–112PubMedCrossRefGoogle Scholar
  50. 50.
    Tam AK, Ilodigwe D, Li Z, Schweizer TA, Macdonald RL (2013) Global cerebral atrophy after subarachnoid hemorrhage: a possible marker of acute brain injury and assessment of its impact on outcome. Acta Neurochir Suppl 115:17–21PubMedGoogle Scholar
  51. 51.
    Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman DG, Tunis S, Bergel E, Harvey I, Magid DJ, Chalkidou K (2009) A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. CMAJ 180:E47–E57PubMedCrossRefPubMedCentralGoogle Scholar
  52. 52.
    Tobin MJ (2008) Counterpoint: evidence-based medicine lacks a sound scientific base. Chest 133:1071–1074PubMedCrossRefGoogle Scholar
  53. 53.
    Tucker WS (1987) The relationship between timing of surgery and operative complications in aneurysmal subarachnoid hemorrhage. Can J Neurol Sci 14:84–87PubMedGoogle Scholar
  54. 54.
    Uhl E, Lehmberg J, Steiger HJ, Messmer K (2003) Intraoperative detection of early microvasospasm in patients with subarachnoid hemorrhage by using orthogonal polarization spectral imaging. Neurosurgery 52:1307–1315PubMedCrossRefGoogle Scholar
  55. 55.
    van der Worp HB, Howells DW, Sena ES, Porritt MJ, Rewell S, O’Collins V, Macleod MR (2010) Can animal models of disease reliably inform human studies? PLoS Med 7:e1000245PubMedCrossRefPubMedCentralGoogle Scholar
  56. 56.
    Vergouwen MD, de Haan RJ, Vermeulen M, Roos YB (2010) Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update. Stroke 41:e47–e52PubMedCrossRefGoogle Scholar
  57. 57.
    Vergouwen MD, Etminan N, Ilodigwe D, Macdonald RL (2011) Lower incidence of cerebral infarction correlates with improved functional outcome after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab 31:1545–1553PubMedCrossRefPubMedCentralGoogle Scholar
  58. 58.
    Vergouwen MD, Frijns CJ, Roos YB, Rinkel GJ, Baas F, Vermeulen M (2004) Plasminogen activator inhibitor-1 4G allele in the 4G/5G promoter polymorphism increases the occurrence of cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke 35:1280–1283PubMedCrossRefGoogle Scholar
  59. 59.
    Vergouwen MD, Vermeulen M, de Haan RJ, Levi M, Roos YB (2007) Dihydropyridine calcium antagonists increase fibrinolytic activity: a systematic review. J Cereb Blood Flow Metab 27:1293–1308PubMedCrossRefGoogle Scholar
  60. 60.
    Vergouwen MD, Vermeulen M, van Gijn J, Rinkel GJ, Wijdicks EF, Muizelaar JP, Mendelow AD, Juvela S, Yonas H, terBrugge KG, Macdonald RL, Diringer MN, Broderick JP, Dreier JP, Roos YB (2010) Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke 41:2391–2395PubMedCrossRefGoogle Scholar
  61. 61.
    Washington CW, Zipfel GJ (2011) Detection and monitoring of vasospasm and delayed cerebral ischemia: a review and assessment of the literature. Neurocrit Care 15:312–317PubMedCrossRefGoogle Scholar
  62. 62.
    Weir B, Grace M, Hansen J, Rothberg C (1978) Time course of vasospasm in man. J Neurosurg 48:173–178PubMedCrossRefGoogle Scholar
  63. 63.
    Yasuno K, Bilguvar K, Bijlenga P, Low SK, Krischek B, Auburger G, Simon M, Krex D, Arlier Z, Nayak N, Ruigrok YM, Niemela M, Tajima A, von Und Zu FM, Doczi T, Wirjatijasa F, Hata A, Blasco J, Oszvald A, Kasuya H, Zilani G, Schoch B, Singh P, Stuer C, Risselada R, Beck J, Sola T, Ricciardi F, Aromaa A, Illig T, Schreiber S, van Duijn CM, van den Berg LH, Perret C, Proust C, Roder C, Ozturk AK, Gaal E, Berg D, Geisen C, Friedrich CM, Summers P, Frangi AF, State MW, Wichmann HE, Breteler MM, Wijmenga C, Mane S, Peltonen L, Elio V, Sturkenboom MC, Lawford P, Byrne J, Macho J, Sandalcioglu EI, Meyer B, Raabe A, Steinmetz H, Rufenacht D, Jaaskelainen JE, Hernesniemi J, Rinkel GJ, Zembutsu H, Inoue I, Palotie A, Cambien F, Nakamura Y, Lifton RP, Gunel M (2010) Genome-wide association study of intracranial aneurysm identifies three new risk loci. Nat Genet 42:420–425PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  1. 1.Division of NeurosurgerySt. Michael’s HospitalTorontoCanada
  2. 2.Labatt Family Center of Excellence in Brain Injury and Trauma ResearchKeenan Research Center of the Li Ka Shing Knowledge Institute of St. Michael’s HospitalTorontoCanada
  3. 3.Department of SurgeryInstitute of Medical Science, University of TorontoTorontoCanada

Personalised recommendations